Apohemoglobin (apoHb) contains vacant hydrophobic
heme-binding pockets that can bind to a variety of hydrophobic molecules. Thus, apoHb is a promising
protein for
drug delivery, bioimaging, and
heme scavenging. Unfortunately, apoHb has a short half-life and precipitates at physiological temperature. In this study, apoHb was surface-conjugated with poly(
ethylene glycol) (PEG) to improve the therapeutic potential of apoHb. The scalable PEGylation process had >95%
protein yield with ∼10 to 12 PEGs attached to each apoHb αβ dimer. The resulting PEG-apoHb had an average molecular weight of ∼80 to 90 kDa and a hydrodynamic diameter of 11 nm. PEG-apoHb maintained high
heme-binding affinity and 30-40% of the
heme-binding activity. Moreover,
heme-bound and
heme-free PEG-apoHb bound to
haptoglobin, enabling PEG-apoHb to potentially target CD163+ macrophages and monocytes. Finally, PEG-apoHb was stable at physiological temperature with minimal precipitation. In summary, the in vitro results shown demonstrate that PEG-apoHb could be an effective in vivo
heme scavenger during states of
hemolysis.